» Articles » PMID: 25267345

Advances in Oral Controlled Drug Delivery: the Role of Drug-polymer and Interpolymer Non-covalent Interactions

Overview
Publisher Informa Healthcare
Specialty Pharmacology
Date 2014 Oct 1
PMID 25267345
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: After more than four decades of intense research, oral controlled drug delivery systems (DDSs) still represent a topic of major interest for pharmaceutical scientist and formulators. This can be explained in part by considering the economic value of oral DDSs whose market accounts for more than half of the overall drug delivery market. Polymeric systems based on drug-polymer non-covalent interaction represent a limited, but growing part of the field. Despite the large amount of literature and published reviews covering specific aspects, there is still need for a review of the relevant literature providing a general picture of the topic.

Areas Covered: The present review aims at presenting the latest findings in drug-polymer and interpolymer non-covalent interactions in oral controlled delivery while providing a specific perspective and a critical point of view, particularly on the tools and methods used for the study of these DDSs. Four main sections are considered: i) ionic interactions between drugs and polymers; ii) interpolymer complexes; iii) hydrogen bond; and iv) hydrophobic interactions.

Expert Opinion: The largest part of the scientific literature deals with systems based on drug-polymer ionic interactions while hydrogen bonding and hydrophobic interaction though, very promising, are more difficult to exploit, and therefore less studied. An accurate and exhaustive representation of the specific role of the chemical functions in establishing predictable interactions between drug and polymers is still required.

Citing Articles

-Carrageenan/Chitosan Nanoparticles via Coacervation: Achieving Stability for Tiny Particles.

Klein R, de Almeida D, de Oliveira A, Bonafe E, Monteiro J, Sabino R Nanomaterials (Basel). 2025; 15(3).

PMID: 39940137 PMC: 11819667. DOI: 10.3390/nano15030161.


An emerging terpolymeric nanoparticle pore former as an internal recrystallization inhibitor of celecoxib in controlled release amorphous solid dispersion beads: Experimental studies and molecular dynamics analysis.

Lugtu-Pe J, Zhang X, Mirzaie S, Chang H, Al-Mousawi N, Chen K Acta Pharm Sin B. 2024; 14(6):2669-2684.

PMID: 38828156 PMC: 11143779. DOI: 10.1016/j.apsb.2024.03.026.


Harnessing polyelectrolyte complexes for precision cancer targeting: a comprehensive review.

Prajapati B, Sharma J, Sharma S, Trivedi N, Gaur M, Kapoor D Med Oncol. 2024; 41(6):145.

PMID: 38727885 DOI: 10.1007/s12032-024-02354-0.


Characteristics of Interpolyelectrolyte Complexes Based on Different Types of Pectin with Eudragit EPO as Novel Carriers for Colon-Specific Drug Delivery.

Nasibullin S, Dunaeva J, Akramova L, Timergalieva V, Moustafine R Int J Mol Sci. 2023; 24(24).

PMID: 38139450 PMC: 10744121. DOI: 10.3390/ijms242417622.


Release of nifedipine, furosemide, and niclosamide drugs from the biocompatible poly(HEMA) hydrogel structures.

Yilmaz B Turk J Chem. 2023; 46(5):1710-1722.

PMID: 37529747 PMC: 10390117. DOI: 10.55730/1300-0527.3474.